You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7608-00 12 CONTAINER in 1 CASE (0264-7608-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7608-10 24 CONTAINER in 1 CASE (0264-7608-10) / 500 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7610-00 12 CONTAINER in 1 CASE (0264-7610-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7610-10 24 CONTAINER in 1 CASE (0264-7610-10) / 500 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7612-00 12 CONTAINER in 1 CASE (0264-7612-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7612-10 24 CONTAINER in 1 CASE (0264-7612-10) / 500 mL in 1 CONTAINER 1988-02-24
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Dextrose 5% and Sodium Chloride 0.11% in Plastic Container

Last updated: August 23, 2025


Introduction

The demand for intravenous (IV) solutions containing Dextrose 5% and Sodium Chloride 0.11% (commonly known as half-normal saline) continues to grow within global healthcare markets. These solutions serve as essential components in fluid therapy, electrolyte balance, and as carriers for IV medications. Ensuring a reliable supply chain for these solutions demands identification of reputable suppliers capable of delivering high-quality products in plastic containers compliant with regulatory standards.

This article delineates key suppliers of Dextrose 5% and Sodium Chloride 0.11% solutions in plastic containers, analyzing their manufacturing capabilities, compliance certifications, geographic reach, and market positioning.


Global Market Landscape for IV Solutions

The global intravenous (IV) fluids market was valued at approximately USD 7 billion in 2022 and projected to expand at a compound annual growth rate (CAGR) of roughly 5% through 2030 [1]. This growth underscores the escalating demand for essential IV solutions, including Dextrose and saline formulations across hospitals, clinics, and pharmaceutical manufacturing.

Major players dominate supply chains, with prominent manufacturers serving both domestic and international markets. Suppliers' selection hinges on their ability to produce sterile, pyrogen-free solutions in compliance with pharmacopeial standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and others.


Leading Suppliers of Dextrose 5% and Sodium Chloride 0.11% in Plastic Containers

1. Baxter International Inc.

Overview:
Baxter is a globally recognized leader in the production of IV fluids, including Dextrose and saline solutions. Their portfolio encompasses a diverse range of sterile, ready-to-use solutions in plastic containers suitable for hospital and pharmaceutical use.

Product Details:

  • Dextrose 5% in Plastic Bag
  • Sodium Chloride 0.9% (normal saline) and lower concentrations, including 0.45% and 0.11% formulations
  • Container types primarily include polyethylene (PE) bags and bottles meeting strict sterility standards

Regulatory Compliance:
Manufactures products adhering to USP, EP, and other global standards, with certifications such as FDA approval, CE marking, and ISO 13485 quality management system certification.

Market Presence:
Baxter supplies to over 100 countries, emphasizing quality and consistency, with extensive distribution channels in North America, Europe, and Asia-Pacific.

Notes:
While Baxter provides a broad range of IV solutions, specific formulations such as Dextrose 5% and Sodium Chloride 0.11% in particular container sizes may require direct inquiry or custom manufacturing arrangements.

2. Hospira, a Pfizer Company (Now part of Pfizer)

Overview:
Hospira has historically been a major manufacturer of sterile IV solutions, including Dextrose and saline solutions in plastic containers, with globally recognized manufacturing facilities.

Product Details:

  • Dextrose solutions for infusion in plastic bags/containers
  • Sodium chloride solutions, including 0.11%, designed for IV administration

Regulatory Compliance:
Manufactures in compliance with cGMP, FDA, and EU standards, with extensive product certification and batch validation protocols.

Market Reach:
Wide global distribution channels, especially prominent in North America and Europe.

Notes:
Post-acquisition integration with Pfizer has expanded their portfolio and market reach, emphasizing innovation in container design and sterile processing.

3. B. Braun Melsungen AG

Overview:
A leading German manufacturer known for producing high-quality hospital products, B. Braun supplies a comprehensive portfolio of sterile IV fluids, including solutions in plastic containers.

Product Details:

  • Dextrose 5% in plastic bottles and bags
  • Sodium Chloride solutions, including 0.11%, in various container formats

Regulatory Compliance:
Certifications include ISO 13485, GMP, and CE marking, with adherence to pharmacopeial standards.

Market Reach:
Strong presence in Europe, Asia, Africa, and expanding in North America, serving both hospital and pharmaceutical manufacturing sectors.


Regional Suppliers and Notable Manufacturers

Beyond global giants, numerous regional suppliers serve local markets with certified IV solutions.

4. Fresenius Kabi

Overview:
Fresenius Kabi specializes in infusion solutions, including Dextrose and saline in plastic containers tailored for clinical use and pharmaceutical manufacturing.

Key Capabilities:

  • manufacturing in Europe, Asia, and South America
  • robust quality control aligned with international standards

5. Baxter Asia-Pacific

Overview:
Baxter's Asia-Pacific operations cater to regional demand, manufacturing Dextrose and saline solutions in various plastic container formats, including pressurized bottles and pouches.


Regulatory and Quality Considerations

Suppliers must comply with stringent quality standards such as USP, EP, JP, and FDA cGMP regulations. Certificates of analysis, stability data, and sterility assurances are critical criteria during selection. Recent trends favor suppliers with ISO 13485 certification and adherence to guidelines for sterile pharmacological manufacturing.


Emerging Suppliers and Contract Manufacturers

Given the growing demand, contract manufacturing organizations (CMOs) and emerging suppliers in India, China, and Southeast Asia are expanding their portfolios. Firms like Bharat Serums & Vaccines Ltd., and Sinovac Biotech, are developing sterile infusion solutions in compliance with international standards, though their market penetration and certification status should be confirmed.


Key Considerations for Procurement

  • Certifications and Regulatory Compliance: Suppliers must possess valid certifications aligned with the target markets' regulatory frameworks.
  • Container Material & Compatibility: Plastic containers should be made from medical-grade, non-reactive polymers such as polyethylene or polyvinyl chloride (PVC) with appropriate additive-free formulations.
  • Supply Chain Reliability: Long-term partnerships should prioritize manufacturers with proven track records of quality assurance, on-time deliveries, and flexible production capabilities.
  • Pricing & Contract Terms: Competitive pricing aligned with quality standards, along with favorable contractual terms, are vital for procurement planning.

Key Takeaways

  • Establish relationships with global and regional leading manufacturers such as Baxter, Pfizer (Hospira), and B. Braun, who adhere to international quality standards and possess extensive distribution networks.
  • Thoroughly verify regulatory compliance, sterility assurance, and container material specifications before procurement.
  • Consider emerging suppliers in high-growth regions for cost-effective alternatives, provided they meet certifiable quality standards.
  • Ensure contractual clarity regarding supply volumes, delivery timelines, and quality guarantees to mitigate supply chain risks.
  • Stay informed of evolving regulatory requirements and industry innovations, such as pre-filled plastic containers with integrated safety features, to optimize procurement strategies.

FAQs

1. Are there regional differences in suppliers for Dextrose 5% and Sodium Chloride 0.11% solutions?
Yes. While global leaders like Baxter and B. Braun serve broad markets, regional manufacturers and CMOs primarily cater to local demand, especially in Asia and emerging markets, often offering cost advantages but with varying certification standards.

2. What are the key certifications to verify in supplier qualification?
Suppliers should possess GMP certification, ISO 13485, and country-specific approvals such as FDA clearance (US), CE marking (Europe), or PMDA approval (Japan). Certification for sterile manufacturing and container material safety is also essential.

3. Is it better to source from single or multiple suppliers?
A diversified supplier base mitigates supply chain risks, ensuring continuity of supply and price competitiveness. However, establishing trusted relationships with primary manufacturers is crucial for consistent quality.

4. Can regional suppliers meet international quality standards?
Some regional suppliers adhere closely to international regulations, but verify their certifications, quality control processes, and third-party audit results before procurement.

5. Are pre-filled plastic containers available for these solutions?
Yes. Many manufacturers now offer pre-filled, ready-to-use plastic containers with integrated safety features. These are increasingly preferred in clinical settings for their convenience and safety enhancements.


References

[1] MarketsandMarkets. “Infusion Therapy & Accessories Market by Product, Application, and Region - Global Forecast to 2030.” 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.